Aquatic High-Intensity Interval Training for Parkinson's Disease
NCT07264114
Summary
This randomized, single-center, parallel-group superiority trial will evaluate the effect of an 8-week aquatic High-Intensity Interval Training (HIIT) program on balance, physical function, and sarcopenia-related outcomes in individuals with Parkinson's disease (PD). The intervention aims to deliver Tabata-style aquatic HIIT (3 sessions/week) in a therapeutic pool to determine adherence and preliminary efficacy compared with standard care (no structured exercise program).
Eligibility
Inclusion Criteria: * PD stages 2-3 based on Hoehn and Yahr classification system * Balance difficulty (BBS score \<45) * Reduced motor function * Sarcopenia (per EWGSOP2 criteria) * Age ≥ 55 * Permission from their doctors to participate * Absence of a history of myocardial infarction within the past 3 months * Capacity to provide informed consent to participate in the study Exclusion Criteria: * Cardiac instability (angina, decompensated congestive heart failure, severe arteriovenous stenosis, uncontrolled arrhythmias, etc.) * Active infection or acute medical illness * Hemodynamic instability * Labile glycemic control * Inability to exercise (e.g. lower extremity amputation with no prosthesis) * Severe musculoskeletal pain at rest or with minimal activity * Inability to sit, stand or walk unassisted (walking device such as cane or walker allowed) * Shortness of breath at rest or with activities of daily living
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07264114